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Neointimal hyperplasia rapidly reaches steady state
in a novel murine vein graft model
Lisheng Zhang, MD,a Per-Otto Hagen, PhD,b Joseph Kisslo, MD,a Karsten Peppel, PhD,a and
Neil J. Freedman, MD,a Durham, NC
Objective: Neointimal hyperplasia remains a principal cause of vein graft failure. Genetic contributions to vein graft
neointimal hyperplasia could be well studied in the mouse; however, surgical approaches to vein bypass surgery in the
mouse have yet to replicate approaches commonly employed in human patients. Consequently, the goal of this study was
to develop a murine interposition vein graft model that reproduces characteristics of human vein graft disease.
Method: Using C57BL/6J mice, we excised inferior venae cavae (IVCs) from donor mice and grafted them, with
end-to-side anastomosis, into the carotid circulation of recipients. IVC grafts were harvested from 3 to 56 days
postoperatively, and analyzed for the development of neointima and media.
Results: Thickening of both the vein graft neointima and media progressed rapidly between postoperative weeks 1 and 4,
and reached steady state levels by approximately week four, with a graft-wall thickness of 91  4 m (14 cell layers), a
lumen area of 0.56 mm2, an average neointima-media ratio of 0.4 to 0.6, and a predominance of -smooth muscle
actin-staining cells. Comprising predominately smooth muscle actin-expressing cells, the neointima was 50% thicker in
the proximal than in the distal third of the grafts (P < .001), but proximal and distal vein graft anastomoses were widely
patent.
Conclusions: In syngeneic murine carotid interposition IVC grafts implanted with end-to-side anastomoses, moderate,
nonocclusive neointimal hyperplasia reaches steady state after the fourth postoperative week. This neointimal hyperplasia,
like that of human grafts, predominates near vein graft anastomoses. This vein graft model should facilitate genetic
analyses of the pathogenesis of neointimal hyperplasia. (J Vasc Surg 2002;36:824-32.)
Arterial bypass graft surgery with autologous vein con-
duits results in neointimal hyperplasia during the process of
vein graft arterialization.1 Involving smooth muscle cell
(SMC) proliferation and migration into the intima as well
as extracellular matrix synthesis,2 neointimal hyperplasia
remains a major obstacle to long-term patency of venous
bypass grafts.1 Despite refinements in surgical technique,
the rate of saphenous vein graft failure remains high: up to
30% of vein grafts become stenotic and require intervention
within 2 years because hemodynamically significant neoin-
timal hyperplasia develops.3 By 10 years, the rate of vein
graft closure may be as high as 50%,1,2,4,5 largely from
accelerated atherosclerosis that arises from the initial vein
graft neointimal hyperplasia.1,6 Control of vein graft neo-
intimal hyperplasia has, therefore, motivated many experi-
mental and clinical trials.7-9
Pathogenic factors important in the development of
vein graft neointimal hyperplasia remain incompletely un-
derstood. To study the gene products important in arterial
neointimal hyperplasia, a number of investigators have
begun to use the mouse as an experimental system because of
the wealth of targeted gene deletions that have been created in
mice.10,11 To engender neointimal hyperplasia, these studies
have employed a variety of arterial endothelial12 or adventi-
tial13,14 injury approaches, as well as arterial ligation.15,16 To
study neointimal hyperplasia in murine vein grafts, rather than
arteries, previous studies have avoided end-to-side graft anas-
tomoses by employing arterial cuffs that facilitate technically
simple ligation of the vein graft to the transected artery.17,18
Thus, these studies cannot assess the important contribution
to vein graft pathology of neointimal hyperplasia at the sites of
end-to-side anastomoses, where most human saphenous vein
grafts tend to fail first.3,19,20 To model human venous bypass
surgery more faithfully in the mouse, we have performed a
series of carotid interposition vein grafts with end-to-side
anastomoses in the C57BL/6J inbred mouse strain. In this
study, we characterize the evolution of these vein grafts
morphologically, to the point of steady state graft wall
thickness.
METHODS
Mice. Adult male C57BL/6J mice weighing 17 to 20 g
were purchased from The Jackson Laboratory (Bar Harbor,
Me). The animals were maintained on a 12-hour light-dark
cycle, and received water and chow ad libitum. All animal
experiments were performed according to protocols ap-
proved by the Institutional Animal Care and Use Commit-
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tee and complied with the Guide for the Care and Use of
Laboratory Animals (National Research Council).
Vein graft surgery. All operative procedures were
performed aseptically, with pentobarbital sodium (50
mg/kg body weight, intraperitoneal) anesthesia, using an
operating microscope (WECK Model 029001 [zoom 3.6-
18], J. K. Hoppl Corporation). A 1-cm segment of
inferior vena cava (IVC) was harvested from a donor mouse
and anastomosed to a syngeneic recipient’s carotid artery.
For IVC preparation, bilateral subcostal incisions were
made in the donor mouse. The anterior chest wall was
separated from the diaphragm, and the anterior rib cage
was divided with heavy scissors on both sides of the sternum
from the lower rib margins to the clavicles. The resulting
hinged thoracic door was lifted to expose the heart and
IVC. The IVC adventitia was removed, and, starting at the
right atrium, a 1-cm length of IVC was excised and washed
with lactated Ringer’s solution containing 50 U/mL hep-
arin; subsequently, the IVC was stored in this heparinized
solution at 25° C until it was transplanted. In the graft
recipient mouse, the right common carotid artery was
exposed by ventral midline incision from the lower mandi-
ble to the sternum. Subsequently, from its take-off from the
brachiocephalic to its bifurcation, a 15-mm segment of the
carotid artery was isolated. This segment of common ca-
rotid artery was then gently occluded proximally and dis-
tally with 5-0 silk suture. Next, two arteriotomies (about
2-mm long) were created proximally and distally, 0.8 to 1
cm apart, with a bent 28-gauge needle and a Vannas angled
scissors (Roboz Surgical, Inc, Rockville, Md) (Fig 1). The
carotid artery was then flushed with heparinized (50
U/mL) saline through the arteriotomies. End-to-side
anastomosis between the IVC and carotid was performed
with 11-0 nylon (Ethicon, Inc, Somerville, NJ), using two
fixed sutures at the proximal and distal corners of each
arteriotomy, and two running sutures, each 180° around
the circumference (with 4-6 bites/180°). The carotid seg-
ment between the IVC anastomoses was ligated at both
ends and cut, thereby stretching the IVC graft. The 5-0 silk
ligatures were then removed from the proximal and distal
common carotid, and patency of the transplanted IVC graft
was confirmed by observing blood flow through the wall of
the turgid graft. The incision was then closed in two layers
with running 5-0 silk sutures. Operative time averaged 20
minutes for IVC harvest and 90 minutes for carotid inter-
position grafting.
IVC graft ultrasonography. Mice were imaged
with a Hewlett Packard Sonos 5500 equipped with a
0.8 x 3 cm transducer (Agilent Technologies) used at a
frequency range of 7 to 15 MHz. To avoid extrinsic graft
compression, we placed anesthetized mice in a water
bath and imaged with the transducer held 2 to 10 mm
from the skin. Ultrasound settings were maximized for
pulse repetition frequency (depth 2 cm, scale factor 3.3
cm/sec). Two-dimensional and color-flow Doppler im-
ages were obtained at a frame rate of 22 Hz. We could
not reliably identify the vein graft anastomoses by use of
ultrasound.
IVC graft harvest and histology. From 3 days to 8
weeks postoperatively, mice were anesthetized, as above,
for IVC graft harvest. The graft was exposed through the
previous surgical incision, and the thoracic cavity was
opened. The right atrium was incised, and the graft was
perfused with phosphate buffered saline by placement of a
22-gauge butterfly angiocatheter in the left ventricle. The
Fig 1. Schematic representation of IVC-to-carotid interposition
grafting in the mouse. The surgical procedure is depicted in four
arbitrary stages, described in Methods section: A, The right com-
mon carotid artery is isolated, ligated proximally and distally, and
arteriotomies are placed 1 cm apart; B, End-to-side anastomoses
are made between the IVC and carotid proximally and distally; C,
The carotid artery is ligated between the two anastomoses; D, The
carotid is cut between interanastomotic ligations, thereby allowing
vein graft stretch. Next, proximal and distal carotid ligatures are
released, and pulsatile flow (dark shading) is observed in the IVC
graft.
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graft was subsequently perfusion-fixed in situ with 10%
buffered formalin for 20 minutes at a constant pressure of
100 mm Hg. To facilitate orientation of the graft during
paraffin embedding, we excised the aortic root and arch
along with the right common carotid, the IVC graft, and
the right carotid bifurcation (Fig 2, B). The graft was
subsequently placed into 10% neutral buffered formalin for
24 hours, and then transferred to 70% ethanol until paraffin
embedding could be accomplished (72 hr). Remnants of
the suture used for anastomosis were employed to orient
the specimen in a vertical position at the time of embed-
ding, thus facilitating cross-sectioning. Sections of 4 m
were subjected to staining with hematoxylin and eosin, as
well as a modified Masson’s trichrome and Verhoeff’s elas-
tic tissue stain, which facilitates the simultaneous identifi-
cation of collagen (green), elastin (black), cytoplasm (red),
and nuclei (black).21 Unless otherwise indicated, IVC sec-
tions for morphometric analysis were obtained 0.5 mm
from the distal anastomosis. We quantitated nuclear density
on enlarged color prints of hematoxylin and eosin–stained
sections, using a grid of 50  50 m squares.
Immunohistochemistry. Serial sections adjacent to
the hematoxylin and eosin–stained sections were processed
for routine immunoperoxidase staining with the anti--
smooth muscle cell actin immunoglobulin (IgG) clone 1A4
(Sigma, Inc). Briefly, sections were de-paraffinized, rehy-
drated, and treated with 0.6% hydrogen peroxide in meth-
anol with subsequent water rinse, to quench endogenous
peroxidase activity. Specimens were then incubated (30
minutes) with Background Buster (Innovex Biosciences,
Inc, Richmond, Calif) to reduce nonspecific IgG binding.
Subsequently, sections were incubated (25°C) serially with
1A4, anti-mouse/biotin, and streptavidin/horseradish
peroxidase, each in 2% bovine serum albumin (BSA)/
phosphate-buffered saline (PBS) for 30 to 60 minutes, with
multiple washes between incubations. Finally, sections
were developed with Vector Red (Vector Labs, Inc, Bur-
lingame, Calif) for 3 minutes, counterstained with hema-
toxylin, dehydrated, and mounted with Permount (Fisher,
Pittsburgh, Pa). For negative control vein graft sections,
incubation with 2% BSA/PBS was substituted for the 1A4
incubation. The positive control for 1A4 was mouse small
intestine. All specimens were run simultaneously, and neg-
ative controls yielded no immunoperoxidase reaction (data
not shown).
Morphometry. Morphometric analyses were per-
formed on tissue stained with the modified Masson’s
trichrome and Verhoeff’s elastic tissue stain.21 Images of
55 original magnification were captured using an RT
SPOT CCD camera (Diagnostic Instruments, Inc, Sterling
Heights, Mich). Perimeter and area measurements for the
lumen, neointima, and media were performed by planim-
etry using Scion Image (Scion Corp, Frederick, Md). These
measurements were then used to create concentric circles of
area or perimeter equivalent to that measured directly from
the vein graft sections, and the radii of these circles were
used to calculate the average thickness of each graft layer
(Fig E1, online only). Perimeter rather than area measure-
ments were ultimately used to calculate graft layer radii,
given that several of the grafts harvested at early time points
failed to hold their cylindrical geometry during fixation and
embedding, and perimeter measurements provided supe-
Fig 2. Anatomic position of and blood flow through the IVC
grafts. A, Photograph taken intraoperatively and B, photograph of
an excised, formalin-fixed specimen demonstrating (1) the proxi-
mal carotid (A) or brachiocephalic (B) artery; (2) the proximal
graft anastomosis; (3) the distal graft anastomosis; (4) the carotid
bifurcation (B only). Black scale bar indicates 1 mm. C, Blood flow
through a single vein graft, imaged by color-flow Doppler scan-
ning. From top to bottom, the image depicts water between the
transducer and the mouse, the mouse’s skin and neck muscles, the
vein graft with blue-coded laminar blood flow within, and deeper
neck structures. White scale bar indicates 2 mm. Shown are results
from a single mouse, representative of three analyzed analogously.
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rior reproducibility, especially for these specimens. Neoin-
tima was recognized both by the criss-cross, random-ap-
pearing orientation of the smooth muscle cells, and by its
predominantly red color, imparted by the prevalence of
SMC cytoplasm and relative paucity (as compared with the
media) of collagen.22 Media was recognized by both the
circular orientation of the SMCs and the green color im-
parted by the prevalence of dense collagen.22 Adventitia
was recognized by the presence of both vasa vasorum and
loose connective tissue.22 To quantitate smooth muscle
actin as a percentage of the graft wall, we used planimetry to
measure the area comprising total graft wall and that com-
prising -smooth muscle actin-staining portions of the
graft wall.
Data analysis. Average thicknesses for each vein graft
layer were calculated by assuming a circular geometry for
each layer, and calculating the radius of the circle corre-
sponding to the relevant perimeter (subtended by the
endothelium [lumen perimeter], neointima/media border,
and media/adventitia border).22 For each IVC specimen,
morphometric measurements were performed on a single
representative section. For each time-point, data from the
indicated number of independent IVC specimens (n 3-8)
were averaged, and this average  standard error (SE) is
presented in all figures. Statistical comparisons among in-
dependent means, when performed, were carried out by
one-way analysis of variance with Tukey post-hoc test for
multiple comparisons (GraphPad Prism).
RESULTS
A view of the operating field at the end of interposition
grafting is found in Fig 2, A, with arrows indicating the
location of the anastomoses between the IVC graft and the
common carotid artery. Fig 2, B, depicts a vein graft after
fixation and explantation, with arrows indicating the posi-
tions of the proximal and distal common carotid, as well as
the aortic arch. The sutures at the anastomoses are clearly
visible, and delineate the margins of the vein graft. The
external diameters of the IVC graft (with associated con-
nective tissue) and the carotid can be visualized in Fig 2, B.
The ratio of IVC to carotid internal diameters was 2.3 
0.3 (n 3). To assess whether blood flow in the vein grafts
was laminar, we subjected mice to ultrasound scanning 3 to
6 weeks postoperatively. By color-flow Doppler ultra-
sonography (Fig 2, C), blood flow through the body of the
vein grafts was laminar (n  3). Twenty-eight mice were
analyzed for our morphologic study, with vein grafts har-
vested postoperatively at 3 days (n 3), 1 week (n 4), 2
weeks (n  4), 4 weeks (n  5), 6 weeks (n  8), and 8
weeks (n  4). The overall perioperative mortality in this
initial cohort was 25%, and the surgical success rate (ie, the
prevalence of patent grafts at the time of harvest) was 80%.
(However, mortality and success rates among the next 40
mice operated were 10% and 95%, respectively.) The
perioperative deaths were related to either anesthesia or
hemorrhage, and graft failures resulted from luminal
thrombosis.
To determine the time course of IVC arterialization
and neointimal hyperplasia in this murine model, we har-
vested IVC-to-carotid grafts at postoperative weeks 0.5, 1,
2, 4, 6, and 8, and examined cross sections of the graft 0.5
mm proximal to the distal anastomosis (Fig 3). IVC graft-
wall thickness—defined as the sum of medial and neointi-
mal thickness—increased approximately ten-fold through
postoperative week 4, and then appeared to stabilize at
91 4 m (Fig 3, B), or 14 cell layers (Fig 3, C). The ratio
of neointimal thickness to medial thickness ranged from 0.4
to 0.6, both at 4 weeks and 6 weeks postoperatively. As
IVC graft arterialization proceeded, luminal area ap-
peared to decrease over the first two postoperative
weeks, and then stabilize at 0.56 0.08 mm2 (Fig 3, D).
Thus, arterialization of the IVC graft in this model
resulted in not only a ten-fold increase in graft-wall
thickness, but also a (statistically insignificant) 16% re-
duction in luminal area.
To assess vein graft maturation further in this model
system, we measured the change with time in the number
of nuclei and smooth muscle cells per unit area of vein graft
wall. Because arterialization of vein grafts includes hyper-
plasia and hypertrophy of SMCs as well as extracellular
matrix secretion,2 stabilization of vein-graft wall cellular
density might be expected to precede stabilization of vein-
graft wall thickness. In a qualitative way, this expectation
appears to be realized in this model: although nuclear
(cellular) density plateaud at 4 weeks postoperatively (Fig
4), vein-graft wall thickness tended to peak at 4 weeks and
decline slightly thereafter (perhaps reflecting progressive
remodeling of the extracellular matrix). Congruently with
the increase in graft nuclear density, SMC actin-positive
cells increased to a steady state 45% of total graft wall area,
also by 4 weeks postoperatively (Fig 4, B). Thus, as in other
vein graft systems,2 the preponderance of neointimal and
medial cells in this murine model appear to be SMCs or
“myofibroblasts.”23
Fixation of the IVC graft specimens that facilitates
cross-sectional analysis of the body of the graft results in
oblique sectioning of the anastomoses between the IVC
and the carotid. As a result, we cannot quantitate the
luminal and graft wall areas at the anastomoses precisely.
Nonetheless, because anastomotic stenoses frequently pro-
duce vein graft failure3,19,20 we examined each of the IVC
graft anastomoses qualitatively (Fig 5). As demonstrated in
Fig 5, IVC grafts demonstrated wide anastomotic patency
at each of the indicated time-points (data for 0.5, 1, 4, and
8 weeks not shown).
Either turbulent blood flow,24 excess growth factor
secretion,19 or both phenomena near vein graft anastomo-
ses may increase neointimal hyperplasia at these sites, or
create variability in the extent of neointimal hyperplasia
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across the length of the graft. To assess these possibilities in
our vein graft model, we studied cross sections of mature
vein grafts, spaced at 0.5-mm intervals across the entire
length of each graft (Fig 6). Fig 6, A, shows a single cross
section from a vein graft harvested 6 weeks postoperatively.
In averaging findings from three vein grafts harvested 6
weeks postoperatively, we found substantial similarity in
the neointimal and medial thicknesses of cognate cross
sections from the three specimens examined (Fig 6, B). By
dividing the grafts into proximal, middle, and distal thirds,
however, we found the neointimal thickness (Fig 6, C and
D) was 50  20% greater in the proximal third than in the
distal third (P  .001)—consistent with the idea that
turbulent flow may predominate more in the proximal than
in the distal graft segments. However, within each of the
proximal, middle, and distal thirds of the grafts, there is
remarkable similarity of neointimal thickness among cross
sections. Indeed, the coefficient of variation on neointimal
thickness among graft cross sections within 1.5 mm of each
other ranged from 12% (distal third) to 29% (middle third).
Congruent with the neointimal measurements, medial
thickness in the proximal as well as middle graft segments
was also greater than that of the distal segment (by 25%-
33%, P  .001), and medial thickness measurements also
demonstrated high reproducibility within segments (Fig 6,
C and D). Thus, this vein graft model would facilitate
comparison of neointimal hyperplasia among distinct vein
grafts: as long as distinct grafts are compared using cross
sections from anatomically similar graft segments (proxi-
mal, middle, or distal), the variation in neointimal or medial
hyperplasia attributable to graft sectioning appears small
enough to facilitate meaningful comparisons among grafts
subjected to different treatments or derived from geneti-
cally different mice.
DISCUSSION
With a syngeneic mouse IVC-to-carotid interposition
vein graft system, we have shown that neointimal hyperpla-
Fig 3. Time course of IVC graft remodeling. A, Representative cross sections of IVC grafts are shown, harvested at the
indicated number of postoperative weeks and stained with a modified connective tissue stain (see Methods). B, Graft
wall thickness determined by morphometry (see Methods) from sections prepared as in panel A is plotted vs the time
of graft harvest (n  3-8 at each time-point). C, Nuclei from graft sections stained with hematoxylin and eosin were
counted to discern the number of cell layers comprising the graft wall at four random points along the graft
circumference. Shown are data from three grafts harvested at each of the indicated time-points. D, Graft lumen areas
determined by morphometry from sections prepared as in panel A are plotted vs the time of graft harvest (n  3-8 at
each time-point). All data are mean  SE. Scale bar indicates 200 m.
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sia and medial thickening develop rapidly, and stabilize by
about 4 weeks postoperatively with regard to graft-layer
thickness, nuclear density, luminal area, and graft-wall
composition measured by either the number of cell layers
or percentage of SMCs. Moreover, we have shown that
both neointimal and medial thickness are asymmetrically
distributed along the length of the IVC graft, and that they
appear most pronounced within the proximal third (neoin-
tima) to two thirds (media) of the graft. In our chow-fed
mice, neointimal hyperplasia did not significantly encroach
on the lumen of the vein graft.
In comparing our murine vein graft model with human
vein grafts, several points should be considered. First, the
diameter of our IVC grafts is 2.3-fold larger than that of the
carotid artery to which they are grafted. Although such a
size discrepancy would be unusual in peripheral arterial
grafting, it would not be unusual in aortocoronary bypass
grafting: saphenous vein segments measuring between 3.5
and 6 mm in diameter can be anastomosed to coronary
Fig 4. IVC graft cellular density and smooth muscle composition
stabilizes by the fourth postoperative week. IVC grafts harvested at
the indicated number of weeks were serially sectioned and stained
either with modified connective tissue stain (Fig 3, A), with
hematoxylin and eosin (H&E), or with immunoperoxidase for
alpha-smooth muscle cell (-SMC) actin (panel A). A, represen-
tative photomicrographs (original magnification,1100) demon-
strating hematoxylin-stained cellular nuclei (note the prevalence of
inflammatory cell nuclei in the 2-week specimen) (H&E), or
reddish brown precipitate specific for -SMC actin. Photomicro-
graphs depict media and neointima only. B, Cell nuclei (left axis)
were counted within a template measuring 2.5 103 m2, at four
random points within each graft cross section examined. Plotted
are the mean SE of measurements made from two grafts at each
time point. SMC Actin (right axis): The percentage of vein graft
wall area comprising SMCs was quantitated by planimetry. Shown
are the means  SE of calculations from three grafts at each
time-point.
Fig 5. IVC graft remodeling at the distal anastomosis. Specimens
harvested at the indicated number of postoperative weeks were
sectioned at the distal anastomosis and stained with a modified
connective tissue stain (see Methods). In each section, the carotid
artery can be recognized by its black elastin fibers. Shown are
sections representative of 3 examined at each time point pre-
sented in Fig 3. Similar data (not shown) were obtained at the
proximal anastomoses. Scale bar indicates 200 m.
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arteries with diameters as small as 1.5 to 2 mm.25Second,
neointimal hyperplasia in the mouse IVC grafts demon-
strated a juxta-anastomotic predominance (in the proximal
third of the graft), much like that reported for human
peripheral saphenous vein grafts.3,26 Thus, the turbulent
blood flow and/or compliance mismatch between artery
and vein graft believed to engender juxta-anastomotic le-
sions in human grafts3,26,27 appears to affect our murine
IVC grafts similarly. Moreover, because the extent of neo-
intimal hyperplasia correlates inversely with laminar shear
stress,24,27,28 the relative attenuation of neointimal hyper-
plasia in the distal two thirds of our IVC grafts suggests that
laminar shear stress increases along the length of our grafts.
Third, in our syngeneic mouse vein graft transplants, as in
vein grafts of human1 and other animal models,2 the neo-
intimal hyperplastic response involves predominately
-smooth muscle actin-stainable, myointimal cells. Lastly,
like the myointimal hyperplasia observed in human aorto-
coronary1 and other animal-model2 vein grafts, neointimal
hyperplasia in our mouse IVC grafts failed, even at steady
state, to produce significant luminal stenosis. Taken to-
gether, these points make a case for biologic similarity
between human vein grafts, or other animal model vein
grafts, and our murine vein graft model. Because of this
similarity, results obtained with our murine model could
plausibly provide mechanistic insights relevant to human
vein graft neointimal hyperplasia.
Unlike our murine IVC-to-carotid graft system, the
first such system to be reported17 avoided direct anastomo-
sis of the vein to the artery. Rather, Zou et al ligated the
IVC to the common carotid artery with the use of polyeth-
ylene17 or nylon18 tubing “cuffs” placed on the cut ends of
the common carotid artery. As a result, Zou et al were
unable to study potential heterogeneity of neointimal hy-
perplasia engendered by the standard end-to-side anasto-
mosis employed in this study. It is of interest that the system
described by Zou et al differed substantially from our
system in other, quantitative aspects. Zou et al found the
total wall thickness of mature vein grafts to be as much as 20
cell layers, or 200 m. By contrast, we found correspond-
ing values in mature vein grafts of only as much as 14 cell
layers, or 90 m. Moreover, whereas our system demon-
strated stabilization of vein graft wall thickness by 4
weeks (much like rabbit autologous jugulocarotid
grafts29), Zou et al observed progressive vein-graft wall
thickening over a period of 16 weeks. This progressive
vein-graft wall thickening resulted in an 80% decrease in
luminal area by 16 weeks postoperatively—presumably
from neointimal hyperplasia, although the morphologic
analysis in the study of Zou et al17 did not discriminate
between neointima and media. By contrast, we observed
only a 16% decrease in luminal area in our mature
(4-week-old) vein grafts. Thus, by using mice geneti-
cally identical to those used in our study, Zou et al
reported a shorter operative time (15 minutes vs approx-
imately 60 minutes ischemic time for the IVC graft), but
Fig 6. The proximal third of mature IVC grafts demonstrates
augmented neointimal hyperplasia. Three IVC grafts harvested 6
weeks postoperatively were sectioned at 0.5-mm intervals along
their entire length, starting 0.5 mm proximal to the distal anasto-
mosis. Each section was stained with a modified connective tissue
stain (see Methods). A, A representative cross section from a single
IVC graft is pictured, with multiple vasa vasorum visible in the
adventitia (and a representative vas vasorum highlighted by the
arrow). Scale bar indicates 200 m. B, Neointimal and medial
thicknesses were calculated morphometrically for each graft at the
indicated distances from the distal anastomosis, and the mean SE
(n  3) are presented (“total wall”  media plus neointima). C,
Each of the three grafts was divided into thirds (comprising four
cross sections); the mean  SE for average neointimal or medial
thickness within the indicated graft tertile is plotted. Compared
with the distal third of the graft: *P  .001. D, A representative
photomicrograph from a single graft cross section stained with the
modified connective tissue stain, demonstrating the delineation of
neointima, media, and adventitia (see Methods). Scale bar indi-
cates 50 m (original magnification, 1100).
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observe what is likely more exuberant neointimal hyper-
plasia than what we observe.
These important differences between our vein graft
system and that devised by Zou et al17 almost certainly
derive from differences in the surgical approaches of the
two systems, given that both systems share the same mouse
genetics, graft source, and artery grafted. The most obvious
difference between the two systems lies in the use of end-
to-side anastomoses in our system and the use of arterial
cuffs by Zou et al. Other differences may also be pertinent.
For example, limiting the extent of hemodynamically in-
duced vein graft expansion with external stenting has been
shown to reduce neointimal hyperplasia.30 Potential differ-
ences in wound closure could create differences in effective
external support of the vein grafts placed in these investi-
gations, and thereby engender differences in vein graft
neointimal hyperplasia.
A chief advantage of the murine IVC graft approach
presented here is that, in this system, neointimal hyperplasia
reaches steady state morphology by postoperative week 4,
and thereby can facilitate relatively short-term intervention
or genetic studies. In addition, because the neointimal
hyperplasia in this model is only moderate in degree, one
could expect to perform experiments in which one could
observe either increases or decreases in the extent of vein
graft neointimal hyperplasia. Ultimately, use of this model
to determine genetic influences on neointimal hyperplasia
will involve transplanting IVCs from not only wild type
(control) mice but also gene-deleted or transgenic mice,
congenic (genetically identical except for the targeted gene
alteration) to the C57BL/6J inbred strain. For this pur-
pose, our model affords an important potential benefit that
can easily be confirmed by serial sectioning of the vein
grafts. If mutant and wild type graft sections are taken
from cognate graft segments (proximal, mid, or distal
thirds), differences in neointimal hyperplasia observed
between mutant and wild type grafts will likely be attrib-
utable to their genetic differences, rather than to heter-
ogeneity of neointimal hyperplasia within cognate graft
segments.
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THE PACIFIC VASCULAR RESEARCH FOUNDATION
IS ACCEPTING APPLICATIONS
FOR THE
2003 WYLIE SCHOLAR AWARD IN ACADEMIC VASCULAR SURGERY
The Wylie Scholar Award was established by the Pacific Vascular Research Foundation to
honor the legacy of Edwin J. Wylie by providing research support to outstanding vascular
surgeon-scientists.
Purpose
The Award is intended to enhance the career development of academic vascular surgeons
with an established research program in vascular disease. The award consists of a grant in
the amount of $50,000 per year for three years. Funding for the second and third years is
subject to review of acceptable progress reports. This three-year award is nonrenewable
and may be used for research support, essential expenses, or other academic purposes at
the discretion of the Scholar and the medical institution. The award may not be used for
any indirect costs.
Eligibility
The candidate must be a vascular surgeon who has completed an accredited residency in
general surgery and who holds a full-time appointment at a medical school accredited by
the Liaison Committee on Medical Educators in the United States or the Committee for
the Accreditation of Canadian Medical Schools in Canada.
How to Apply
The applications are due by February 1, 2003, for the award to be granted July 1, 2003.
Applications may be obtained by writing to: Pacific Vascular Research Foundation, Wylie
Scholar Award, 3627 Sacramento Street, San Francisco, CA 94118.
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